[go: up one dir, main page]

DK3517956T3 - Modifikationsafhængige aktivitetsassayer - Google Patents

Modifikationsafhængige aktivitetsassayer Download PDF

Info

Publication number
DK3517956T3
DK3517956T3 DK19161002.1T DK19161002T DK3517956T3 DK 3517956 T3 DK3517956 T3 DK 3517956T3 DK 19161002 T DK19161002 T DK 19161002T DK 3517956 T3 DK3517956 T3 DK 3517956T3
Authority
DK
Denmark
Prior art keywords
activity assays
dependent activity
modification dependent
modification
assays
Prior art date
Application number
DK19161002.1T
Other languages
English (en)
Inventor
Andrea Engelmaier
Hans-Peter Schwarz
Alfred Weber
Original Assignee
Takeda Pharmaceuticals Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceuticals Co filed Critical Takeda Pharmaceuticals Co
Application granted granted Critical
Publication of DK3517956T3 publication Critical patent/DK3517956T3/da

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854Immunoglobulins
    • G01N33/6857Antibody fragments
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2440/00Post-translational modifications [PTMs] in chemical analysis of biological material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)
DK19161002.1T 2011-05-18 2012-05-18 Modifikationsafhængige aktivitetsassayer DK3517956T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161487612P 2011-05-18 2011-05-18
EP12725954.7A EP2710375B1 (en) 2011-05-18 2012-05-18 Modification-dependent activity assays

Publications (1)

Publication Number Publication Date
DK3517956T3 true DK3517956T3 (da) 2021-10-11

Family

ID=46208807

Family Applications (2)

Application Number Title Priority Date Filing Date
DK12725954.7T DK2710375T3 (da) 2011-05-18 2012-05-18 Modifikationsafhængige aktivitetstests
DK19161002.1T DK3517956T3 (da) 2011-05-18 2012-05-18 Modifikationsafhængige aktivitetsassayer

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK12725954.7T DK2710375T3 (da) 2011-05-18 2012-05-18 Modifikationsafhængige aktivitetstests

Country Status (11)

Country Link
US (1) US8785139B2 (da)
EP (3) EP2710375B1 (da)
JP (5) JP6175426B2 (da)
AU (2) AU2012255066B2 (da)
CA (1) CA2836103C (da)
DK (2) DK2710375T3 (da)
ES (2) ES2893605T3 (da)
PL (2) PL2710375T3 (da)
PT (2) PT3517956T (da)
TR (1) TR201904997T4 (da)
WO (1) WO2012159084A1 (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102375055A (zh) * 2010-08-19 2012-03-14 中国人民解放军军事医学科学院微生物流行病研究所 一种多重检测免疫层析芯片
WO2014074756A1 (en) * 2012-11-09 2014-05-15 Children's Medical Center Corporation Methods and reagents for glycoproteomics
CN103819907B (zh) * 2014-03-10 2016-04-06 山东理工大学 一种用聚丙二醇与聚乙烯醇对聚肽膜亲水性进行改进的方法
AU2015257929B2 (en) * 2014-05-05 2020-06-25 Novio Th B.V. Method for the serological diagnosis of rheumatoid arthritis.
CN104559207B (zh) * 2015-01-05 2017-02-22 山东理工大学 一种聚氨基甲酸酯与聚丙烯酸改进聚肽膜亲水性与柔顺性的方法
CN104559206B (zh) * 2015-01-05 2017-02-22 山东理工大学 一种聚三亚甲基碳酸酯与聚丙烯酰胺改进聚肽膜亲水性与柔顺性的方法
CN104448842B (zh) * 2015-01-06 2016-08-31 山东理工大学 一种聚乳酸与聚丙烯酸改进聚肽膜亲水性与柔顺性的方法
CN104448843B (zh) * 2015-01-06 2016-10-05 山东理工大学 一种聚己内酯与聚丙烯酸改进聚肽膜亲水性与柔顺性的方法
CN104448841B (zh) * 2015-01-06 2016-08-31 山东理工大学 一种聚乳酸乙醇酸与聚丙烯酸改进聚肽膜亲水性与柔顺性的方法
CN104530722B (zh) * 2015-01-12 2017-05-03 山东理工大学 一种聚乳酸乙醇酸与羧甲基壳聚糖改进聚肽膜亲水性与柔顺性的方法
CN104559224B (zh) * 2015-01-12 2017-02-22 山东理工大学 一种聚丙二醇与水性聚氨酯改进聚肽膜亲水性与柔顺性的方法
CN104479367B (zh) * 2015-01-12 2016-08-31 山东理工大学 一种聚乳酸与水性聚氨酯改进聚肽膜亲水性与柔顺性的方法
US9804170B2 (en) 2015-02-09 2017-10-31 Bristol-Myers Squibb Company Antibodies to polyethylene glycol
JP6552286B2 (ja) * 2015-06-05 2019-07-31 公立大学法人奈良県立医科大学 凝固第viii因子の複合体形成能に関する情報の取得方法および試薬キット
US11845989B2 (en) 2019-01-23 2023-12-19 Regeneron Pharmaceuticals, Inc. Treatment of ophthalmic conditions with angiopoietin-like 7 (ANGPTL7) inhibitors
CA3126476A1 (en) 2019-01-23 2020-07-30 Regeneron Pharmaceuticals, Inc. Treatment of ophthalmic conditions with angiopoietin-like 7 (angptl7) inhibitors
CN110118847B (zh) * 2019-05-17 2021-08-10 重庆派金生物科技有限公司 确定多位点peg修饰蛋白质修饰位点的分析方法
CA3210480A1 (en) 2021-02-26 2022-09-01 Regeneron Pharmaceuticals, Inc. Treatment of inflammation with glucocorticoids and angiopoietin-like 7 (angptl7) inhibitors
US20240353431A1 (en) * 2021-08-20 2024-10-24 Takeda Pharmaceutical Company Limited Selective measurement of human factor viii
EP4490042A1 (en) 2022-03-08 2025-01-15 Equashield Medical Ltd. Fluid transfer station in a robotic pharmaceutical preparation system

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3244030A1 (de) 1982-11-27 1984-05-30 Behringwerke Ag, 3550 Marburg Chromogene verbindungen, verfahren zu ihrer herstellung und ihre verwendung
US5208148A (en) 1990-12-07 1993-05-04 Molecular Probes, Inc. Lipophilic fluorescent glycosidase substrates
US5576424A (en) 1991-08-23 1996-11-19 Molecular Probes, Inc. Haloalkyl derivatives of reporter molecules used to analyze metabolic activity in cells
EP0603266B1 (en) 1991-08-23 1999-05-12 Molecular Probes, Inc. Use of haloalkyl derivatives of reporter molecules to analyze metabolic activity in cells
US5242805A (en) 1991-08-23 1993-09-07 Molecular Probes, Inc. Long wavelength lipophilic fluorogenic glycosidase substrates
US5830912A (en) 1996-11-15 1998-11-03 Molecular Probes, Inc. Derivatives of 6,8-difluoro-7-hydroxycoumarin
US5773236A (en) 1997-04-25 1998-06-30 Molecule Probes, Inc. Assay for glutathiane transferase using polyhaloaryl-substituted reporter molecules
JP2005536723A (ja) * 2002-08-22 2005-12-02 ベクトン・ディキンソン・アンド・カンパニー 痴呆に関連した神経学上の障害を診断する方法
CN101678119B (zh) 2006-12-27 2014-02-12 尼克塔治疗公司 具有可释放的键合的血管性血友病因子-和因子ⅷ-聚合物轭合物
WO2009006620A1 (en) * 2007-07-03 2009-01-08 Children's Hospital & Research Center At Oakland Oligosialic acid derivatives, methods of manufacture, and immunological uses
KR20170072365A (ko) * 2007-12-27 2017-06-26 백스터 인터내셔널 인코포레이티드 생리학적으로 수용가능한 중합체 분자를 특이적으로 검출하기 위한 방법 및 조성물
NZ585530A (en) * 2007-12-27 2012-06-29 Baxter Int Methods for differentiating plasma-derived protein from recombinant protein in a sample
KR20100119899A (ko) * 2008-04-03 2010-11-11 에프. 호프만-라 로슈 아게 폴리에틸렌글리콜화된 인슐린 유사 성장 인자 분석법
WO2010048184A2 (en) * 2008-10-21 2010-04-29 Baxter International Inc. Methods for determining active ingredients in pro-drug peg protein conjugates with releasable peg reagents (in vitro de-pegylation)
NZ597600A (en) 2009-07-27 2014-05-30 Lipoxen Technologies Ltd Glycopolysialylation of non-blood coagulation proteins
US8642737B2 (en) 2010-07-26 2014-02-04 Baxter International Inc. Nucleophilic catalysts for oxime linkage
WO2011017055A2 (en) 2009-07-27 2011-02-10 Baxter International Inc. Blood coagulation protein conjugates
GB2488532B (en) * 2011-02-18 2013-06-05 Sca Ipla Holdings Inc Communication units and methods for control change notification in broadcast communication

Also Published As

Publication number Publication date
EP3517956A1 (en) 2019-07-31
ES2893605T3 (es) 2022-02-09
US8785139B2 (en) 2014-07-22
US20120329072A1 (en) 2012-12-27
EP3943939A1 (en) 2022-01-26
PT3517956T (pt) 2021-10-15
JP2019035765A (ja) 2019-03-07
PT2710375T (pt) 2019-05-08
CA2836103A1 (en) 2012-11-22
DK2710375T3 (da) 2019-04-29
JP2021063816A (ja) 2021-04-22
JP2017161536A (ja) 2017-09-14
WO2012159084A1 (en) 2012-11-22
TR201904997T4 (tr) 2019-05-21
CA2836103C (en) 2020-07-14
ES2720138T3 (es) 2019-07-18
JP6175426B2 (ja) 2017-08-02
AU2016203387A1 (en) 2016-06-16
JP2014524010A (ja) 2014-09-18
EP3517956B1 (en) 2021-09-08
JP7242627B2 (ja) 2023-03-20
AU2016203387B2 (en) 2018-01-25
EP2710375B1 (en) 2019-03-13
EP2710375A1 (en) 2014-03-26
PL3517956T3 (pl) 2021-12-20
PL2710375T3 (pl) 2019-07-31
JP6863950B2 (ja) 2021-04-21
AU2012255066B2 (en) 2016-06-02
JP7618714B2 (ja) 2025-01-21
JP2023081972A (ja) 2023-06-13
AU2012255066A1 (en) 2013-05-02

Similar Documents

Publication Publication Date Title
HUS2300021I1 (hu) Anti-IL-36R antitestek
DK3517956T3 (da) Modifikationsafhængige aktivitetsassayer
DK3467500T3 (da) Cobinder-understøttede assayfremgangsmåder
DE112012000866A5 (de) Durchführung
CO6811812A2 (es) Anticuerpo anti-b7-h3
DK2744810T4 (da) Tenofovir-alafenamid-hemifumarat
BR112014002399A2 (pt) conjunto
CR20140127A (es) Anticuerpo anti-abtcr
DK2769050T3 (da) Propsensor
DE102011100082A8 (de) Traygreifvorrichtung
BR112014000879A2 (pt) deflegmador
DK3272861T3 (da) Alpha-galactosidase-sammensætninger
EP2701512A4 (en) Aldosterone synthase inhibitors
CO6960543A2 (es) 2-tiopirimidinonas
DK3141251T3 (da) Koloskopi - forberedelse
EP2760629A4 (en) CONSTRUCTION OF A CONICAL STRUCTURE
EP2695208A4 (en) MICRO THERMOCOUPLE
DE112011104936A5 (de) Stanzstauchniet
CO6841994A2 (es) Anticuerpos
EP2752241A4 (en) CATALYST
DE112012000958A5 (de) Handsäge
EP2698098A4 (en) campimeter
DK2476953T3 (da) Fluidbedkedel
DE112012002458A5 (de) Hydrotransformator
DE112012000819A5 (de) Gurtbandfänger